Development and Application of a Measurement Framework to Evaluate Safe, Effective and Efficient Medication Use Among Older Adults.


Journal

Drugs - real world outcomes
ISSN: 2199-1154
Titre abrégé: Drugs Real World Outcomes
Pays: Switzerland
ID NLM: 101658456

Informations de publication

Date de publication:
Dec 2019
Historique:
pubmed: 29 8 2019
medline: 29 8 2019
entrez: 29 8 2019
Statut: ppublish

Résumé

A majority of older adults in the United States (US) use prescription medications. Comprehensive population-level approaches to examine medication safety, effectiveness, and costs among older adults are needed. The objectives of this study were to develop a framework of quality measures spanning the domains of safety, effectiveness, and efficiency of prescription medication use among older adults, and to apply those measures using pharmacy claims data. We performed a retrospective study among adults age 65 years and older of a US East Coast state who filled at least one prescription from a particular pharmacy chain during 2016 (N = 99,056). Firstly, we performed an environmental scan to identify quality measures and potentially relevant measures addressing prescription medication use. These measures were reviewed and rated by local geriatric pharmacotherapy experts. After evaluating feasibility, evidence, and relevance, a total of 19 measures representing the domains of safety (n = 7), effectiveness (n = 7), and efficiency (n = 5) were identified. These measures were then applied to an older adult population using prescription data for the year 2016 provided by a national pharmacy chain. All measures were configured such that a score of 100% corresponded to optimal performance. For the domain of safety, 12.8% of patients received a benzodiazepine chronically, 23.6% received central nervous system depressants, 16.7% received fluoroquinolones as first-line antibiotic therapy, and 21.9% of those who were prescribed opioids received them in excessive quantities. For the domain of effectiveness, one-fourth of the diabetes patients did not receive statins and angiotensin-acting medications, while 18.0% were not adherent to oral anticoagulant medications and 54% were not adherent to respiratory inhalers. For the domain of efficiency, 12.0% of the patients received prescriptions from five or more unique prescribers. Overall, 85.7%, 76.1%, and 87.9% of the older adults showed safe, effective, and efficient prescription medication use, respectively. A novel approach to comprehensively examine the quality of medication use among older adults using prescription claims data is provided in our study. A considerable proportion of the older adults in our study received safe, effective, and efficient prescription medications. However, within each domain, several opportunities for improving the alignment of prescription medication use with current recommendations were identified.

Sections du résumé

BACKGROUND BACKGROUND
A majority of older adults in the United States (US) use prescription medications. Comprehensive population-level approaches to examine medication safety, effectiveness, and costs among older adults are needed.
OBJECTIVES OBJECTIVE
The objectives of this study were to develop a framework of quality measures spanning the domains of safety, effectiveness, and efficiency of prescription medication use among older adults, and to apply those measures using pharmacy claims data.
METHODS METHODS
We performed a retrospective study among adults age 65 years and older of a US East Coast state who filled at least one prescription from a particular pharmacy chain during 2016 (N = 99,056). Firstly, we performed an environmental scan to identify quality measures and potentially relevant measures addressing prescription medication use. These measures were reviewed and rated by local geriatric pharmacotherapy experts. After evaluating feasibility, evidence, and relevance, a total of 19 measures representing the domains of safety (n = 7), effectiveness (n = 7), and efficiency (n = 5) were identified. These measures were then applied to an older adult population using prescription data for the year 2016 provided by a national pharmacy chain. All measures were configured such that a score of 100% corresponded to optimal performance.
RESULTS RESULTS
For the domain of safety, 12.8% of patients received a benzodiazepine chronically, 23.6% received central nervous system depressants, 16.7% received fluoroquinolones as first-line antibiotic therapy, and 21.9% of those who were prescribed opioids received them in excessive quantities. For the domain of effectiveness, one-fourth of the diabetes patients did not receive statins and angiotensin-acting medications, while 18.0% were not adherent to oral anticoagulant medications and 54% were not adherent to respiratory inhalers. For the domain of efficiency, 12.0% of the patients received prescriptions from five or more unique prescribers. Overall, 85.7%, 76.1%, and 87.9% of the older adults showed safe, effective, and efficient prescription medication use, respectively.
CONCLUSION CONCLUSIONS
A novel approach to comprehensively examine the quality of medication use among older adults using prescription claims data is provided in our study. A considerable proportion of the older adults in our study received safe, effective, and efficient prescription medications. However, within each domain, several opportunities for improving the alignment of prescription medication use with current recommendations were identified.

Identifiants

pubmed: 31456064
doi: 10.1007/s40801-019-00162-x
pii: 10.1007/s40801-019-00162-x
pmc: PMC6879678
doi:

Types de publication

Journal Article

Langues

eng

Pagination

173-181

Références

Cad Saude Publica. 2009 Mar;25(3):605-12
pubmed: 19300849
Geriatr Gerontol Int. 2017 Jun;17(6):999-1005
pubmed: 27426234
Am J Geriatr Pharmacother. 2007 Dec;5(4):345-51
pubmed: 18179993
Arch Intern Med. 2009 Jul 27;169(14):1326-32
pubmed: 19636035
J Manag Care Spec Pharm. 2018 Nov;24(11):1126-1129
pubmed: 30362914
Age Ageing. 2015 Mar;44(2):213-8
pubmed: 25324330
Curr Med Res Opin. 2015;31(10):1889-95
pubmed: 26211815
J Am Geriatr Soc. 2018 Jul;66(6):1180-1185
pubmed: 29430639
Ann Intern Med. 2004 May 4;140(9):714-20
pubmed: 15126255
Drugs Aging. 2012 May 1;29(5):359-76
pubmed: 22550966
BMC Geriatr. 2017 Oct 10;17(1):230
pubmed: 29017448
J Clin Epidemiol. 1992 Oct;45(10):1045-51
pubmed: 1474400
J Am Pharm Assoc (2003). 2017 May - Jun;57(3S):S236-S242.e1
pubmed: 28506378
Int J Clin Pharmacol Ther. 2008 Feb;46(2):72-83
pubmed: 18218287
J Manag Care Spec Pharm. 2016 Jan;22(1):40-8
pubmed: 27015050
Ann Am Thorac Soc. 2016 Sep;13(9):1497-504
pubmed: 27332765
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1280-88
pubmed: 16868217
Maturitas. 2017 Jul;101:17-22
pubmed: 28539164
Psychiatr Serv. 2019 Feb 1;70(2):97-106
pubmed: 30554562
Home Healthc Now. 2017 Jun;35(6):304-313
pubmed: 28562400
Can J Aging. 2010 Jun;29(2):205-13
pubmed: 20420748
JAMA. 2010 Oct 13;304(14):1592-601
pubmed: 20940385
Med Care. 2007 Jan;45(1):95-9
pubmed: 17279026
J Am Geriatr Soc. 2009 Jun;57(6):1096-102
pubmed: 19473455
J Am Geriatr Soc. 2015 Oct;63(10):2074-81
pubmed: 26415836
Pain Med. 2014 Jul;15(7):1083-90
pubmed: 24341376
J Am Geriatr Soc. 2019 Apr;67(4):674-694
pubmed: 30693946
Ann Pharmacother. 2007 Mar;41(3):438-47
pubmed: 17311835
Ann Intern Med. 2007 Dec 4;147(11):755-65
pubmed: 18056659
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49
pubmed: 26987082
J Gerontol A Biol Sci Med Sci. 2015 Aug;70(8):989-95
pubmed: 25733718

Auteurs

Ami Vyas (A)

Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, 7 Greenhouse Road, Kingston, RI, 02881, USA. avyas@uri.edu.

Emily Patry (E)

Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, 7 Greenhouse Road, Kingston, RI, 02881, USA.

Norma Owens (N)

Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, 7 Greenhouse Road, Kingston, RI, 02881, USA.

Nicholas Belviso (N)

Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, 7 Greenhouse Road, Kingston, RI, 02881, USA.

Stephen J Kogut (SJ)

Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, 7 Greenhouse Road, Kingston, RI, 02881, USA.

Classifications MeSH